Press Releases 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 FDA Grants Priority Review for Eagle Pharmaceuticals’ Ryanodex NDA for the Treatment of Exertional Heat Stroke 3/27/17 Eagle Pharmaceuticals Announces Three New Patents Issued for Bendeka 3/21/17 Eagle Pharmaceuticals Appoints Richard A. Edlin to Board of Directors 3/16/17 Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2016 Results 3/1/17 Eagle Pharmaceuticals’ Pemetrexed NDA Accepted for Filing by the FDA 2/28/17 Eagle Pharmaceuticals Announces 11th Patent Issued for Bendeka 2/28/17 Eagle Pharmaceuticals Announces New Patents Issued for Bendeka 2/21/17 Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2016 Financial Results on March 1, 2017 2/16/17 Eagle Pharmaceuticals to Present at 2017 RBC Capital Markets Global Healthcare Conference 2/13/17 Eagle Pharmaceuticals Completes NDA Submission for Ryanodex for Exertional Heat Stroke to FDA 1/23/17 Pagination First page Previous page Page 1 Page 2 Current page 3 Page 4 Next page Last page
